Extended-Release Morphine Does Not Reduce Breathlessness in COPD

WEDNESDAY, Nov. 30, 2022 (HealthDay News) -- Daily low-dose extended release morphine does not significantly reduce the intensity of worst breathlessness among people with chronic obstructive pulmonary disease (COPD) and severe chronic breathlessness, according to a study published in the Nov. 22/29 issue of the Journal of the American Medical Association.
Magnus Ekström, M.D., Ph.D., from Lund University in Sweden, and colleagues conducted a double-blind trial involving people with COPD and chronic breathlessness at 20 centers in Australia. A total of 160 participants were randomly assigned to 8 mg/day or 16 mg/day of oral extended-release morphine or placebo during week 1 in a 1:1:1 ratio. Participants were randomly assigned to 8 mg/day extended-release morphine, added to the previous dose, or placebo in a 1:1 ratio at the start of weeks 2 and 3. Overall, 138 participants completed treatment at week 1.
The researchers found that the change in the intensity of worst breathlessness at week 1 did not differ significantly between the 8-mg/day morphine and placebo groups or between the 16-mg/day morphine and placebo groups. The secondary outcome of change in mean daily step count was not significantly different between the 8-mg/day and placebo groups, the 16-mg/day and placebo groups, the 24-mg/day and placebo groups, or the 32-mg/day and placebo groups at week 3.
"These findings do not support the use of these doses of extended-release morphine to relieve breathlessness," the authors write.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Related Posts
Bleeding Events Up With Full-Dose Thromboprophylaxis in COVID-19
FRIDAY, Feb. 4, 2022 (HealthDay News) -- For hospitalized COVID-19 patients,...
Flu Shots Cut Some Cardiac Complications in Patients With Heart Failure
WEDNESDAY, Nov. 23, 2022 (HealthDay News) -- Flu shots reduce some cardiac...
Lecciones de un incendio forestal sobre cómo salvar las vidas de las mascotas
LUNES, 13 de febrero de 2023 (HealthDay News) -- Tras desastres naturales como...
Inability to Afford Prescription Meds, Specialty Care More Likely for Adults With Epilepsy
FRIDAY, May 27, 2022 (HealthDay News) -- Adults with active and inactive...
